HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.

Abstract
Treatment limitations exist for drug-resistant Acinetobacter baumannii central nervous system (CNS) infection. We conducted a retrospective study and systematic literature review to identify patients with drug-resistant A. baumannii CNS infection who received primary or adjunct intrathecal or intraventricular (IT/IVT) colistin. In a case series of seven Thai patients and 17 patients identified in the literature, clinical and microbiological cure rates with IT/IVT colistin therapy were 83% and 92%, respectively. Three patients (13%) developed chemical ventriculitis and one (4%) experienced treatment-associated seizures. Death was associated with delayed IT/IVT colistin therapy compared to survival (mean time from diagnosis to IT/IVT colistin, 7 vs. 2 days; p 0.01). The only independent predictor of mortality was the severity of illness (APACHE II score > 19, adjusted odds ratio 49.5; 95% CI 1.7-1428.6; p 0.02). This case series suggests that administration of primary or adjunctive IT/IVT colistin therapy was effective for drug-resistant A. baumannii CNS infection.
AuthorsT Khawcharoenporn, A Apisarnthanarak, L M Mundy
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 16 Issue 7 Pg. 888-94 (Jul 2010) ISSN: 1469-0691 [Electronic] England
PMID19686281 (Publication Type: Case Reports, Journal Article, Review, Systematic Review)
Chemical References
  • Anti-Bacterial Agents
  • Colistin
Topics
  • APACHE
  • Acinetobacter Infections (drug therapy, microbiology)
  • Acinetobacter baumannii (drug effects)
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents (administration & dosage, pharmacology, therapeutic use)
  • Central Nervous System Bacterial Infections (drug therapy, microbiology)
  • Central Nervous System Infections (drug therapy)
  • Child
  • Child, Preschool
  • Colistin (administration & dosage, adverse effects, pharmacology, therapeutic use)
  • Cross Infection (drug therapy, epidemiology, microbiology)
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Humans
  • Injections, Intraventricular
  • Injections, Spinal
  • Male
  • Middle Aged
  • Risk Factors
  • Thailand
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: